Inhibition of Myeloma Cell Growth by All-Trans Retinoic Acid is Associated with Upregulatidn of p21 and Dephosphorylation of the Retinoblastoma Protein

References

• Klein B., Zhang X-G., Lu Z-Y., Bataille R. Interleukin-6 in multiple myeloma. Blood 1995; 85: 863–872
   PubMed Web of Science ®Google Scholar
• Kehrl J. H., Roberts A. B., Wakefield L. M., Jakelow S., Spom M. B., Fauci AS. Transforming growth factor b˜ is an important immunoregulatory protein for B lymphocytes. J Immunol 1986; 137: 3855–3860
   PubMed Web of Science ®Google Scholar
• Urashima M., Ogata A., Chauhan D., Hatziyanni M., Vid-Riales M. B., Dedera D. A., Schlossman R. L., Anderson K. C. Transforming growth factor b˜-1: differential effects on multiple myeloma versus normal B cells. Blood 1996; 87: 1928–1938
   PubMed Web of Science ®Google Scholar
• Urashima M., Ogata A., Chauhan D., Vidriales M. B., Teoh G., Hoshi Y., Schlossman R. L., DeCaprio J. A., Anderson K. C. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood 1996; 88: 2219–2227
   PubMed Web of Science ®Google Scholar
• Halleck M., Bergsagel P. L., Anderson K. C. Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 1998; 91: 3–21
   PubMed Web of Science ®Google Scholar
• Sidell N., Taga T., Hirano T., Kishimoto T., Saxon A. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol 1991; 146: 3809–3814
   PubMed Web of Science ®Google Scholar
• Ogata A., Nishimoto N., Shima Y., Yoshizaki K., Kishimoto T. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukind signal transduction. Blood 1994; 84: 3040–3046
   PubMed Web of Science ®Google Scholar
• Palumbo A., Battaglio S., Napoti P., Bruno B., Omede P., Boccadoro M., Pileri A. Retinoic acid inhibits the growth of human myeloma cells in vitro. Br J Haemarol 1995; 89: 555–560
   PubMed Web of Science ®Google Scholar
• Cben Y-H., Desai P., Shiao R-T., Lavelle D., Haleem A., Chen J. Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: Synergy through modulation of interleukind autocrine loop at multiple sites. Blood 1996; 87: 314–323
   PubMed Web of Science ®Google Scholar
• Chen Y-H., Shiao R-T., Labayog J-M., Modi S., Lavelle D. Modulation of interleukin-6/interleukin-6 receptor cytokine loop in the treatment of multiple myeloma. Leuk Lymph 1997; 27: 1–23, 1
   PubMedGoogle Scholar
• Lavelle D., Chen Y-H. Constitutive expression of the IL-6 receptor does not alleviate retinoic acid-mediated gowth inhibition of a human myeoma cel line. Blood 1997; Suppl 1: 351a–1997
   Google Scholar
• Andrews N. C., Faller D. V. A rapid microprepara-tion technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991; 19: 2499
   PubMed Web of Science ®Google Scholar
• Sheaff R. J. Regulation of mammalian cyclin-depen-dent kinase 2. Meth Enzymol 1997; 283: 173–193
   PubMed Web of Science ®Google Scholar
• Urashima M., Teoh G., Chauhan D., Hoshi Y., Ogata A., Treon S. P., Schlossman R. L., Anderson K. C. Interleukin-6 overcomes p21 WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-γ in multiple myeloma cells. Blood 1997; 90: 279–289
   PubMed Web of Science ®Google Scholar
• Musto P., Sajeva M. R., Sanpaolo G., D'Arena G., Scalzuli P. R., Carotenuto M. All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myclorna. Haematologica 1997; 82: 354–356
   PubMedGoogle Scholar
• Weinberg R. A. The retinoblastoma protein and cell cycle progression. Cell 1995; 81: 323–330
   PubMed Web of Science ®Google Scholar
• Chesi M., Bergsagel P., Brents L. A., Smith C. M., Gerhard D. S., Kuehl W. M. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 1996; 88: 674–681
   PubMed Web of Science ®Google Scholar
• Ng M. H. L., Chung Y. F., Lo K. W., Wickham N. W. R., Lee J. C. K., Huang D. P. Frequent hypemethylation of p16 and p15 genes in multiple myeloma. Blood 1997; 89: 2500–2506
   PubMed Web of Science ®Google Scholar
• Liu M., Iavarone A., Freedman L. P. Transcrip-tional activation of the human p21WAFl/CP1 gene by retinoic acid receptor. J Biol Chem 1996; 271: 31723–31728
   PubMed Web of Science ®Google Scholar
• Chin Y. E., Kitagawa M., Su W. C., You Z. H., Iwamoto Y., Fu X. Y. Cell growth arrest and induction of cyclin-dependent kinase inibitor p21 WF1/CIP1 mediated by STATl. Science 1996; 272: 719–722
   PubMed Web of Science ®Google Scholar
• Matikainen S., Ronni T., Lehtonen A., Sareneva T., Melen K., Nordling S., Levy D. E., Julkunen I. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons. Cell Growth Differ 1997; 8: 687–688
   PubMedGoogle Scholar
• Matikainen S., Lehtonen A., Sareneva T., Julkunen I. Regulation of IRF and STAT gene expression by rctinoic acid. Leuk Lymph 1998; 30: 63–71
   PubMed Web of Science ®Google Scholar
• Cram E. J., Ramos R. A., Wang E. C., Cha H. H., Nishio Y., Firestone G. L. Role of the CCAAT/Enhancer binding-α transcription factor in the glucocorticoid stimulation of p21 WAF1/CIp1 gene promoter activity in growth arrested rat heptoma cells. J Biol Chem 1998; 273: 2008–2014
   PubMed Web of Science ®Google Scholar
• Timchenko N. A., Wilde M., Nakanishi M., Smith J. R., Darlington G. J. CCAAT/enhance-binding protein a (C/EBPa) inhibits cell proliferation through the p21 (WAF-1/CIp-1/SDI-1) protein. Genes Dev 1996; 10: 804–815
   PubMed Web of Science ®Google Scholar